Glycemic Index Laboratories
Toronto, Ontario, M5C 2X3, Canada
NCT Number: NCT02795559
It has been suggested that obesity occurs because the colonic microbes in obese individuals, compared to those who are lean, produce more short chain fatty acids during the fermentation of dietary fiber; this means that obese individuals obtain more energy from dietary fiber than lean. On the other hand, it is possible that the ability of colonic short chain fatty acids to improve glycemic control and suppress appetite may be reduced in obese subjects. The aim of this study was to determine the acute effects of 2 fibers commonly used as food ingredients, inulin and resistant starch, on postprandial serum responses of short chain fatty acids, glucose, insulin, free-fatty acids and selected gut hormones in lean and overweight or obese subjects.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Toronto, Ontario, M5C 2X3, Canada
The human colon (large intestine) contains hundreds of species of bacteria which exist in a symbiotic (mutually beneficial) relationship with their human host. The number and type of colonic bacteria varies in different people. Recent studies show that overweight individuals have different types of bacteria in their colons than lean subjects, and that as overweight subjects lose weight their colonic bacteria change to resemble those in lean subjects. It was suggested that this was because the bacteria in overweight people more efficiently ferment dietary fiber thus producing more SCFAs and providing more energy to the body. However, this is not consistent with other studies showing that high fiber intakes are associated with reduced risk of obesity.
Some studies have shown that overweight people have higher concentrations of SCFA in their stool samples. But the reasons for the difference in stool concentrations of SCFA have not been studied. Stool concentrations of SCFA may differ in lean and overweight people because of differences in type of bacteria in their colons, differences in dietary intakes or maybe because lean and overweight people absorb SCFA produced by bacteria differently.
Therefore, the objectives of this study were to:
Healthy subjects with a BMI <25 (lean) or between 25 and 35 (overweight or obese; OWO) took part in a 2 phase study. In phase 1 subjects recorded their dietary intake for 3 days and then provided a stool sample for analysis of micro-organisms and short chain fatty acids. In phase 2 overnight fasted subjects were studied on 3 occasions separated by about a week. On each occasion subjects consumed a control test meal of dextrose, or dextrose plus inulin or dextrose plus resistant start and had breath and blood samples taken at intervals over 4 hours. Subjects were then given a standardized lunch and had more blood and breath samples taken over the next 2 hours.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
75g glucose dissolved in 300ml water
75g glucose plus 24g inulin dissolved in 300ml water
75g glucose plus 28g resistant starch in 300ml water
Time frame: 0 to 6 hours after the intervention
Incremental area under the curve of the serum acetate response from the lowest concentration achieved during the first 3 hours to the end of the study (6hr)
Time frame: 0 to 6 hours after the intervention
Incremental area under the curve of the serum propionate response from the lowest concentration achieved during the first 3 hours to the end of the study (6hr)
Time frame: 0 to 6 hours after the intervention
Incremental area under the curve of the serum butyrate response from the lowest concentration achieved during the first 3 hours to the end of the study (6hr)
Time frame: 0 to 6 hours after the intervention
Incremental area under the curve of the breath hydrogen response from the lowest concentration achieved during the first 3 hours to the end of the study (6hr)
Time frame: 3 days
From 3-day diet record, mean energy intake.
Time frame: 3 days
From 3-day diet record, mean total fat intake.
Time frame: 3 days
From 3-day diet record, mean protein intake.
Time frame: 3 days
From 3-day diet record, mean available carbohydrate intake.
Time frame: 3 days
From 3-day diet record, mean dietary fiber intake.
Time frame: 1 day
Ion Torrent V6 16S-rRNA sequencing for comparison of phyla
Time frame: 0 to 2 hours after consuming treatment
Incremental area under the curve of the serum glucose response from fasting to 2 hours.
Time frame: 2 to 4 hours after consuming treatment
Incremental area under the curve of the serum glucose response from 2 to 4 hours.
Time frame: 0 to 2 hours after lunch
Total area under the curve of the serum glucose response for 2 hours after lunch.
Time frame: 0 to 2 hours after consuming treatment
Incremental area under the curve of the serum insulin response from fasting to 2 hours
Time frame: 2-4 hours after consuming treatment
Incremental area under the curve of the serum insulin response from 2 to 4 hours.
Time frame: 0-to 2 hours after lunch
Total area under the curve of the serum insulin response for 2 hours after lunch.
Time frame: 0 to 2 hours after consuming treatment
Incremental area under the curve of the serum c-peptide response from fasting to 2 hours.
Time frame: 2 to 4 hours after consuming treatment
Incremental area under the curve of the serum c-peptide response from 2 to 4 hours.
Time frame: 0-2 hours after lunch
Total area under the curve of the serum c-peptide response for 2 hours after lunch.
Time frame: 0 to 4 hours after consuming intervention
Increase in serum free-fatty acid concentration from the lowest to the subsequent highest concentration before consuming lunch
Time frame: 0 to 4 hours after consuming intervention
Incremental area under the curve of the serum total glucagon-like peptide-1 response from 0 to 4 hours.
Time frame: 0 to 2 hours after consuming lunch
Incremental area under the curve of the serum total glucagon-like peptide-1 response from 0 to 2 hours after lunch.
Time frame: 0 to 4 hours after consuming intervention
Incremental area under the curve of the serum active glucagon-like peptide-1 response from 0 to 4 hours.
Time frame: 0 to 2 hours after consuming lunch
Incremental area under the curve of the serum active glucagon-like peptide-1 response from 0 to 2 hours after lunch.
Time frame: 0 to 4 hours after consuming intervention
Incremental area under the curve of the serum PYY response from 0 to 4 hours.
Time frame: 0 to 2 hours after consuming lunch
Incremental area under the curve of the serum PYY response from 0 to 2 hours after lunch.
Time frame: 0 to 4 hours after consuming intervention
Incremental area under the curve of the serum ghrelin response from 0 to 4 hours.
Time frame: 0 to 2 hours after consuming lunch
Incremental area under the curve of the serum ghrelin response from 0 to 2 hours after lunch.
University of Toronto
Other
Role of Colonic Short Chain Fatty Acids in Obesity: Acute Effects of Inulin and Resistant Starch on Postprandial Short Chain Fatty Acid, Glucose, Insulin, Free-fatty Acid and Gut Hormone Responses
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00065676
Body Weight, Diabetes
Bethesda, Maryland, United States
View Trial DetailsNCT00862433
Body Weight, Diabetes
Bethesda, Maryland, United States
View Trial DetailsNCT01809288
Behavior, Body Weight
Bethesda, Maryland, United States
View Trial DetailsNCT01501201
Body Weight, Diabetes
Lille, Nord, France
View Trial Details